I am working with development of Fondaparinux Sodium Prefilled Syringe Injection. But I am struggling with unspecified impurity generation in the finished product. How can I solve this issue? The inactive excipients are similar to RLD product (ARIXTRA) and is Sodium Chloride. and pH is adjusted with NaOH or HCL if necessary.

Similar questions and discussions